Stay updated on PCSK9 Inhibitors in HoFH Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibitors in HoFH Clinical Trial page.

Latest updates to the PCSK9 Inhibitors in HoFH Clinical Trial page
- Check5 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, indicating a potential improvement or addition in functionality or security.SummaryDifference0.8%
- Check12 days agoChange DetectedThe service alert has been updated to reflect a planned maintenance period beginning on July 25th, with most services being unavailable for over 24 hours starting at 9 PM EDT. The revision number has also changed from v2.16.5 to v2.16.6.SummaryDifference2%
- Check19 days agoChange DetectedA service alert has been added regarding planned maintenance on July 26th, indicating that most services will be unavailable for over 12 hours starting at 6 AM EDT.SummaryDifference4%
- Check27 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a note regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.SummaryDifference4%
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check48 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
Stay in the know with updates to PCSK9 Inhibitors in HoFH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibitors in HoFH Clinical Trial page.